ERBB2 and breast cancer: However, a clinical study indicated that a high expression of β2-adrenergic receptors may be associated with improved prognosis in early BC patients with HER2+ receptor status [58], indicating a potential decrease in BC prognosis when blocking the β2-adrenergic receptor in HER2+ patients.